Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03407976
Title Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Utah
Indications

gastric adenocarcinoma

Advanced Solid Tumor

colorectal cancer

transitional cell carcinoma

gastroesophageal junction adenocarcinoma

Therapies

Pembrolizumab + Rivoceranib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.